Daniel is a member of the Patents Technology & Life Sciences Practice Area. His practice focuses on advising and representing national and international pharmaceutical companies and medical device manufacturers, with a particular emphasis on drug advertising law and regulatory issues in the field of pharmaceutical and medical device law.
by Irina Rebin and Daniel Dietrich
Reform of the Veterinary Medicines Act
German requirements protecting the supply of critical medicinal products and medical devices
by multiple authors
by Irina Rebin
by Irina Rebin
by multiple authors
by Dr. Benedikt Groh and Fritz Krings
by Ross McNaughton and Oli Denne
by multiple authors
by multiple authors
by multiple authors
by Kathleen Munstermann-Senff, LL.M. (Medical Law) and Dr. Martin Jäger